Dallas, TXNCT07408232Now EnrollingIRB Ready

Retinitis Pigmentosa Clinical Trial in Dallas, TX

Access cutting-edge retinitis pigmentosa treatment through this phase 1/2 clinical trial at a research site in Dallas. Study-provided care at no cost to qualified participants.

Sponsored by Octant, Inc.

Quick Self-Assessment

See if you qualify for this Dallas location

Preparing your pre-screening questions…

Expert Care in Dallas

Access retinitis pigmentosa specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related retinitis pigmentosa treatment provided free

Apply for This Dallas Location

Check if you qualify for this retinitis pigmentosa clinical trial in Dallas, TX

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Dallas

    Convenient for TX residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Dallas site if eligible
  4. 4Begin participation

About This Retinitis Pigmentosa Study in Dallas

This integrated Ph1/2 clinical study is to assess the safety, tolerability and pharmacokinetics (PK), pharmacodynamics (PD) and efficacy of OCT-980 in healthy volunteers and participants with RHO-adRP.

Sponsor: Octant, Inc.

Who Can Participate

Inclusion Criteria

Phase 1b/2 (Multiple Ascending Dose Escalation in RHO-adRP Patients) Inclusion:
Participants must have a diagnosis of Rhodopsin-associated, autosomal dominant Retinitis Pigmentosa confirmed by a genetic test that is implemented in accordance with the relevant national requirements
Male or female greater than or equal to age 18 (inclusive) at the time of signing the informed consent form
Have a body weight \>50kg, with a body mass index (BMI) from 18.0 to 35.0 kg/m\^2 (inclusive) at screening
Best Corrected Visual Acuity (BCVA) using the Early Treatment Diabetic Retinopathy Study (ETDRS) \> 55
Other than their diagnosis of RHO-adRP, be in good general health, as determined by the Investigator
Have sufficient venous access to allow blood sampling for pharmacokinetic analysis and safety laboratory samples Phase 1b/2 (Multiple Ascending Dose Escalation in RHO-adRP Patients)

Exclusion Criteria

Females who are pregnant or breastfeeding
Evidence of any other significant ocular (other than RHO-adRP) and non-ocular disease/ disorder
Lifetime history of ocular surgery
Any prior or current ophthalmologic gene therapy
Has a history of major surgery, severe trauma, or bone fracture within 12 weeks before the first dose of the investigational product or planned surgery within 4 weeks after the end of the study

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Dallas?

Yes, this clinical trial (NCT07408232) has an active research site in Dallas, TX that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Retinitis Pigmentosa Treatment Options in Dallas, TX

If you're searching for retinitis pigmentosa treatment options in Dallas, TX, this clinical trial (NCT07408232) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Dallas research site is actively enrolling participants for this phase 1/2 clinical trial. You'll receive care from experienced retinitis pigmentosa specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all retinitis pigmentosa clinical trials near you to find additional studies recruiting in your area.

More Essential Tremor Trials in Dallas, TX

See all essential tremor clinical trials recruiting in Dallas — not just this study.

Browse Essential Tremor Trials in Dallas →

Browse More Trials by Condition

Essential Tremor TrialsSleep Apnea TrialsRetinitis Pigmentosa TrialsMyalgic Encephalomyelitis TrialsAll Conditions →

Ready to Join in Dallas?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Dallas, TX